Description
PHARMACEUTICALS 770-24-2-801-0301 -NATIONAL CMOP NALTREXONE
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-03-11+$1,086,494= $1,086,494
- Mod P000012024-04-19-$798,554= $287,940
- Mod P000022024-09-13-$94,828= $193,112
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-03-11 | +$1,086,494 | $1,086,494 | PHARMACEUTICALS 770-24-2-801-0301 -NATIONAL CMOP NALTREXONE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-04-19 | −$798,554 | $287,940 | PHARMACEUTICALS 770-24-2-801-0301 -NATIONAL CMOP NALTREXONE |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-13 | −$94,828 | $193,112 | PHARMACEUTICALS 770-24-2-801-0301 -NATIONAL CMOP NALTREXONE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PX72BSBQTKJ3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77021P0530 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $37,080 | FY2021 |
| 36C77020P0981 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
| 36C77020P0750 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $70,886 | FY2020 |
| 36C77020P0656 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $2,711 | FY2020 |
| 36C77020P0630 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $35,110 | FY2020 |
| 36C77020P0609 | NATIONAL CMOP OFFICE (36C770) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2020 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77024P0197_3600_-NONE-_-NONE- · retrieved 2026-09-26.